期刊
JOURNAL FOR IMMUNOTHERAPY OF CANCER
卷 4, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s40425-016-0190-5
关键词
Negative checkpoint regulators; Combination immunotherapy; VISTA
资金
- National Institutes of Health [1R01AI098007]
Negative checkpoint regulators function to restrain T cell responses to maintain tolerance and limit immunopathology. However, in the setting of malignancy, these pathways work in concert to promote immune-mediate escape leading to the development of a clinically overt cancer. In the recent years, clinical trials demonstrating the efficacy of blocking antibodies against these molecules have invigorated the field of immunotherapy. In this review, we discuss the current understanding on established NCR blockade and how strategic combination therapy with anti-VISTA antibody can be used to target multiple non-redundant NCR pathways.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据